Know Labs’ first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor’s accuracy and medical application. SEATTLE--(BUSINESS WIRE) ...

The KnowU incorporates the sensor that the Company plans to submit to the FDA for clearance. This proprietary sensor has been tested and proven stable and accurate in the lab setting. It was included ...

Apollon and an MIT lab today shared clinical findings demonstrating the accuracy of their non-invasive continuous glucose ...

For many years now, it has been rumored that the Apple Watch will eventually gain non-invasive blood sugar monitoring ...

Glucose tracking is moving beyond diabetes care as CGMs, AI platforms, and wearable sensors reshape personalized health data and wellness tools.

Echo Therapeutics, creator of a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system called Symphony and a transdermal drug delivery system called Prelude SkinPrep, recently ...